Sunday, October 19, 2025

Latest

PharmaDrug Engages Research Lab To Advance Patented Cocaine Synthesis Method

FULL DISCLOSURE: This content is sponsored by PharmaDrug Inc.

PharmaDrug (CSE: PHRX) has formally engaged a research lab to refine and advance the development of its patented cocaine synthesis process.

The lab, Chiral Logistics Corp, is based in Victoria, BC, where it specializes in chemical synthesis, bio-synthesis, extractions, and isolations of active chemical substances. The research and development lab focuses on operating on a contractual basis to drive innovation in the pharma and biotech sectors.

The processes developed by the lab will remain as the wholly owned IP of SecureDose, the wholly-owned subsidiary of PharmaDrug that currently holds the IP on the novel cocaine synthesis method.

WATCH: PharmaDrug: A Path To Safe Supply

“We are extremely excited to begin working with Chiral Labs. The work will focus on both fine tuning the process and producing a test batch to prove out our method and formulation. We will also seek to partner with a licensed contract commercial manufacturer to collaborate on tactical commercial methods with a goal to begin producing a larger commercial batch early next year,” commented CEO Robert Steen.

PharmaDrug last traded at $0.035 on the CSE.


FULL DISCLOSURE: PharmaDrug is a client of Canacom Group, the parent company of The Deep Dive. Canacom Group is currently long the equity of PharmaDrug. The author has been compensated to cover PharmaDrug on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

When 4% of Global Copper Disappears Overnight | David Gower – Emerita Resources

Mining M&A: Gold X2 Acquires Kesselrun Resources

They Said Oil Was Dead. They Were Wrong. | Michael Judson – Record Resources

Recommended

Military Seizes Power in Madagascar After President Flees

Altamira Gold Hits 395.5 Metres Of 0.4 g/t Gold At Maria Bonita

Related News

PharmaDrug Joint Venture Receives Approval For Phase 1 Clinical Trial

Pharmadrug Inc (CSE: PHRX) has received approval for its majority owned joint venture, Sairiyo Therapeutics,...
Monday, August 19, 2024, 09:08:46 AM

Pharmadrug Completes Super Smart Acquisition, Issues 64.4 Million Free Trading Shares

Pharmadrug Inc (CSE: BUZZ) announced this morning that it has completed its acquisition of Interrobang...

Monday, June 15, 2020, 02:44:06 PM

PharmaDrug Subsidiary Begins Prep Work For Clinical Trial Of PD-001 For Viral Infectious Diseases

PharmaDrug (CSE: PHRX) yesterday reported that its joint venture, Sairiyo Therapeutics, has begun the process...
Friday, September 20, 2024, 08:29:02 AM

Pharmadrug Signs Five Year Supply Agreement With Canada House Wellness

Canada House Wellness (CSE: CHV) and Pharmadrug (CSE: BUZZ) jointly announced today a five year...

Thursday, October 31, 2019, 12:20:18 PM

Biosynthetic Cocaine? PharmaDrug Files Patent For Novel Manufacturing Method

PharmaDrug's (CSE: PHRX) subsidiary SecureDose has finally revealed its first biosynthetic formulation: pharmaceutical grade cocaine....
Wednesday, March 13, 2024, 08:45:11 AM